{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:17:49Z","timestamp":1725149869360},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jacig.2024.100293","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T14:32:14Z","timestamp":1718289134000},"page":"100293","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tolerability and outcomes with rollout of tixagevimab-cilgavimab in patients with common variable immunodeficiency"],"prefix":"10.1016","volume":"3","author":[{"given":"Daniela","family":"Dluzynski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taha","family":"Al-Shaikhly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catharine I.","family":"Paules","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Paula","family":"Henao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2024.100293_bib1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s10875-021-01174-5","article-title":"Immunogenicity of anti-SARS-CoV-2 vaccines in common variable immunodeficiency","volume":"42","author":"Arroyo-S\u00e1nchez","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100293_bib2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/iid3.450","article-title":"COVID-19 infection in CVID patients: what we know so far","volume":"9","author":"Weifenbach","year":"2021","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jacig.2024.100293_bib3","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s10875-023-01468-w","article-title":"Impaired B cell recall memory and reduced antibody avidity but robust T cell response in CVID patients after COVID-19 vaccination","volume":"43","author":"Steiner","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100293_bib4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijid.2023.06.021","article-title":"Monoclonal antibodies as COVID-19 prophylaxis therapy in immunocompromised patient populations","volume":"134","author":"Cowan","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jacig.2024.100293_bib5","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa2116620","article-title":"Intramuscular AZD7442 (tixagevimab-cilgavimab) for prevention of Covid-19","volume":"386","author":"Levin","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2024.100293_bib6","unstructured":"EVUSHELD: emergency use authorization (EAU)\u2014full fact sheet for healthcare providers. 2022. Available from: https:\/\/www.fda.gov\/media\/154701\/download. Accessed April 27, 2023."},{"key":"10.1016\/j.jacig.2024.100293_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3390\/v15010118","article-title":"Tixagevimab\/cilgavimab in SARS-CoV-2 prophylaxis and therapy: a comprehensive review of clinical experience","volume":"15","author":"Akinosoglou","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jacig.2024.100293_bib8","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1111\/ajt.17128","article-title":"Tixagevimab\/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave","volume":"22","author":"Al Jurdi","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jacig.2024.100293_bib9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.14740\/jh1062","article-title":"Real-world effectiveness of tixagevimab and cilgavimab (Evusheld) in patients with hematological malignancies","volume":"11","author":"Ocon","year":"2022","journal-title":"J Hematol"},{"year":"2023","series-title":"FDA announces Evusheld is not currently authorized for emergency use in the","key":"10.1016\/j.jacig.2024.100293_bib10"},{"key":"10.1016\/j.jacig.2024.100293_bib11","article-title":"Safety and tolerability of Evusheld in patients with CVID: the Mayo Clinic experience","volume":"2","author":"Squire","year":"2023","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.jacig.2024.100293_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10875-021-01150-z","article-title":"COVID-19 in CVID: a case series of 17 patients","volume":"42","author":"Greenmyer","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100293_bib13","doi-asserted-by":"crossref","first-page":"1654.e1","DOI":"10.1016\/j.cmi.2022.07.015","article-title":"Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients","volume":"28","author":"Nguyen","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jacig.2024.100293_bib14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.anai.2020.06.006","article-title":"Positive outcome in a patient with coronavirus disease 2019 and common variable immunodeficiency after intravenous immunoglobulin","volume":"125","author":"Aljaberi","year":"2020","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829324000894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829324000894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T08:16:48Z","timestamp":1725092208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829324000894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2772829324000894"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2024.100293","relation":{},"ISSN":["2772-8293"],"issn-type":[{"type":"print","value":"2772-8293"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tolerability and outcomes with rollout of tixagevimab-cilgavimab in patients with common variable immunodeficiency","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2024.100293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100293"}}